| Patents for C07K - Peptides (3,738) |
|---|
| 05/10/2002 | WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | US20020052594 Method and kit for imaging and treating organs and tissues |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP0746567B1 Novel opioid peptides for the treatment of pain and use thereof |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
| 04/30/2002 | US6380162 Ice inhibiting peptides |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/18/2002 | WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 04/18/2002 | CA2425809A1 Humanized anti-lt-.beta.-r antibodies |
| 04/17/2002 | EP1196444A1 Peptides that lower blood glucose levels |
| 04/17/2002 | CN1345251A Methods and compositions for healing and repair of articular cartilage |
| 04/17/2002 | CN1082821C Antibody cojugates |
| 04/16/2002 | US6372222 Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| 04/10/2002 | EP0752876B1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/03/2002 | EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/27/2002 | EP0782452B1 Cell growth regulator |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362161 Copolymer-1 improvements on compositions of copolymers |
| 03/21/2002 | WO2002022776A2 Human coagulation factor vii variants |
| 03/21/2002 | WO2002022168A2 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | WO2002022167A2 Vaccine against streptococcus penumoniae |
| 03/21/2002 | CA2422002A1 Vaccine |
| 03/21/2002 | CA2421998A1 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | CA2420892A1 Human coagulation factor vii variants |
| 03/20/2002 | EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 03/14/2002 | US20020031526 Reacting with a base to form a de-n-acetylated product, and depolymerizing with a nitrosation agent |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028178 Treating CD40+ malignancies comprising administering a therapeutically effective amount of an antibody or antibody fragment which binds to CD40L thereby inhibiting CD40/CD40L interaction or CD40 signaling. |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016410A2 Peptide selection method |
| 02/28/2002 | DE10040700A1 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung Salts of biologically active peptides, their preparation and use |
| 02/21/2002 | WO2002014347A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 02/21/2002 | WO2001077140A3 Measurement of nutrient uptake in cells and methods based thereon |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/06/2002 | EP0835305A4 Cytokine that induces apoptosis |
| 02/06/2002 | EP0762888B1 Copolymer-1 improvements in compositions of copolymers |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | CA2416657A1 Fh-binding protein of streptococcus pneumoniae |
| 01/29/2002 | US6342476 Treating multiple sclerosis by administering a copolymer reacted with hydrobromic acid |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004494A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | CA2415100A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
| 01/03/2002 | WO2001036471A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 01/02/2002 | CN1329620A Analogues of GLP-1 |
| 12/19/2001 | CN1076356C Protein having TPO activity |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/13/2001 | US20010051708 Purifying antibody; prepare antibody suspension, mix with water soluble liquid, recover clarified antibody, apply to chromatography column, elute antibody, concentrate antibody |
| 12/12/2001 | EP1162264A2 Chimeric hormone receptor |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/05/2001 | EP0763114B1 Hepatitis g virus and molecular cloning thereof |
| 12/05/2001 | EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 12/04/2001 | CA2046880C Substituted alkylamide derivatives of teicoplanin |
| 12/04/2001 | CA2027635C Erythropoietin isoforms |
| 11/28/2001 | CN1324251A Method of stimulating prosaposin receptor activity |
| 11/21/2001 | EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction |
| 11/21/2001 | CN1075078C Producing process of stem cell factor |
| 11/15/2001 | WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses |
| 11/15/2001 | CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses |
| 11/14/2001 | EP1066380B1 Soluble t cell receptor |
| 11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
| 11/01/2001 | WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 11/01/2001 | CA2407523A1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 10/25/2001 | WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 10/24/2001 | CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway |
| 10/18/2001 | WO2001077145A2 Integrin binding peptide derivatives |
| 10/18/2001 | WO2001077140A2 Measurement of nutrient uptake in cells and methods based thereon |
| 10/17/2001 | EP1144454A2 Modified peptides as therapeutic agents |
| 10/17/2001 | CN1073158C Anti-egfr single-chain Fvs and anti-egfr antibodies |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/10/2001 | EP1141308A2 Group b streptococcus proteins, and their use |
| 10/10/2001 | EP1140994A1 Outer surface proteins, their genes, and their use |
| 10/10/2001 | EP1140993A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 10/09/2001 | US6300475 Interferon PRO655 |
| 10/04/2001 | EP1137667A2 Analogues of glp-1 |
| 10/03/2001 | CN1315961A Glycopeptide derivatives and pharmaceutical compositions containing same |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |